Skip to main content

Lupus

      RT @KDAO2011: Dr. P Crow #PhilipHenchLecture
      IFN signature can parallel or predict flares #ACR21 @rheumnow https://t.co/

      TheDaoIndex KDAO2011

      3 years 10 months ago
      Dr. P Crow #PhilipHenchLecture IFN signature can parallel or predict flares #ACR21 @rheumnow https://t.co/OskxDuKPDH
      RT @_Castillo_Pedro: Soluble urinary ALCAM previously shown as potential biomarker for LN. Further study showing urinary

      Pedro Castillo _Castillo_Pedro

      3 years 10 months ago
      Soluble urinary ALCAM previously shown as potential biomarker for LN. Further study showing urinary ALCAM trended with changes in renal-SLEDAI and UPCr. #ACR21 Abst#3053 @RheumNow https://t.co/IqVJej7yda
      RT @bella_mehta: Important to discuss men with #lupus
      Nationwide claims study showed increased occurrence of multimorbi

      Bella Mehta bella_mehta

      3 years 10 months ago
      Important to discuss men with #lupus Nationwide claims study showed increased occurrence of multimorbidity in men with SLE compared to women with SLE #ACR21 @RheumNow @AliDuarteMD Abst#0579 #ACRBest https://t.co/ljflGU84Ro
      RT @uptoTate: Ear dyspigmentation, scalp dyspigmentation and scarring alopecia found more frequently in Black DLE pts. F

      Dr. Rachel Tate uptoTate

      3 years 10 months ago
      Ear dyspigmentation, scalp dyspigmentation and scarring alopecia found more frequently in Black DLE pts. Findings may help assist in dx and tx plans. Abs 0598 #ACR21 #RheumNow #ACRbest @RheumNow https://t.co/a1pxWHJ7b5
      The RheumNow faculty have been glued to their monitors all day, watching video, and running down abstract presentations to find the best – several of these stood out as #ACRBests. Here is a listing of “Best” they saw on Day 1.
      Lung Now: Drs. Pope and Sparks
      RT @RHEUMarampa: Factors associated w/ poor COVID19 outcomes in #SLE from the GRA @rheum_covid
      📌Demographics - age,

      sheila RHEUMarampa

      3 years 10 months ago
      Factors associated w/ poor COVID19 outcomes in #SLE from the GRA @rheum_covid 📌Demographics - age, sex, region 📌Glucocorticoid use 📌 Comorbids - renal, CV 📌Untreated/active dse ❗Very important msg here: Control dse, manage comorbids & avoid GCs @RheumNow #ACR21 abs0866 https://t.co/eXR3KqGrJa
      RT @Janetbirdope: #SLE pts will.... answer in abst#0858 #ACR2021 @RheumNow

      Janet Pope Janetbirdope

      3 years 10 months ago
      #SLE pts will.... answer in abst#0858 #ACR2021 @RheumNow
      RT @Janetbirdope: Good news for #COVID vaccine in #SLE. ✅doesn’t cause #lupus flares ➡️ no increase in APS. Wha

      Janet Pope Janetbirdope

      3 years 10 months ago
      Good news for #COVID vaccine in #SLE. ✅doesn’t cause #lupus flares ➡️ no increase in APS. What about #SARS-CoV2 infection in SLE. Flares ↔️ stable but ⬆️APS Abs. from Hopkins cohort. Petri #ACRBest #ACR21 abst0858 @RheumNow https://t.co/ABx4C4lwvs
      ACR21 Daily Recap Day 1
      Lupus Updates: Dr. Michelle Petri
      RT @KDAO2011: Dr. Petri noted that 1 week off of immunosuppressants is adequate for most lupus patients to mount a respo

      TheDaoIndex KDAO2011

      3 years 10 months ago
      Dr. Petri noted that 1 week off of immunosuppressants is adequate for most lupus patients to mount a response. She avoided RTX during the pandemic. In pts who have had inadequate response to 2 or 3 doses of mRNA, she switches them to J&J. #ACR21 #COVI19 CH @rheumnow https://t.co/qNjmx9uTLF
      RT @KDAO2011: HSS Study of 136 SLE flares post-vax:
      👉100 (74%) w/expected AE (headache/myalgias)
      👉11 (8.1%) pts w

      TheDaoIndex KDAO2011

      3 years 10 months ago
      HSS Study of 136 SLE flares post-vax: 👉100 (74%) w/expected AE (headache/myalgias) 👉11 (8.1%) pts with SLE flare 👉Majority of flares were mild-mod & occurred w/in 1 week of vaccination 👉Most resolved w/in 7 days. Abst#0896 #ACR21 @rheumnow https://t.co/e6AP8PPRH2
      ×